4.8 Article

Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells

Journal

CELL
Volume 138, Issue 3, Pages 592-603

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2009.07.011

Keywords

-

Funding

  1. California Breast Cancer Research Program of the University of California [12FB-0053]
  2. Fundacion Alfonso Martin Escudero
  3. Fulbright
  4. NIH [CA100225, CA104987, CA126524, CA139490]
  5. Breast Cancer Research Foundation
  6. Morton Family Foundation
  7. Ludwig Foundation

Ask authors/readers for more resources

Human breast tumors contain a breast cancer stem cell (BCSC) population with properties reminiscent of normal stem cells. We found 37 microRNAs that were differentially expressed between human BCSCs and nontumorigenic cancer cells. Three clusters, miR-200c-141, miR-200b-200a-429, and miR-18396-182 were downregulated in human BCSCs, normal human and murine mammary stem/progenitor cells, and embryonal carcinoma cells. Expression of BMI1, a known regulator of stem cell self-renewal, was modulated by miR-200c. miR-200c inhibited the clonal expansion of breast cancer cells and suppressed the growth of embryonal carcinoma cells in vitro. Most importantly, miR-200c strongly suppressed the ability of normal mammary stem cells to form mammary ducts and tumor formation driven by human BCSCs in vivo. The coordinated downregulation of three microRNA clusters and the similar functional regulation of clonal expansion by miR-200c provide a molecular link that connects BCSCs with normal stem cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available